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Abstract. Two studies were conducted to replicate and 
extend previous demonstrations of smoking-induced, 
dose-related reports of euphoria, and to confirm this 
relationship using measures of plasma nicotine. In exper- 
iment 1, overnight-deprived subjects, in three different 
sessions, smoked ultralow-, high-nicotine, and usual- 
brand cigarettes. In experiment 2, ultralow-, medium-, 
and high-nicotine cigarettes were used, and plasma nico- 
tine was measured. In both studies, subjects were asked 
to depress a button during euphoric sensations. Number 
of sensations for the uttralow-nicotine cigarette was sig- 
nificantly lower than for the high-nicotine cigarette in 
the first study, and than for both the medium- and high- 
nicotine conditions in the second; a significant linear 
trend was observed for number of sensations as a func- 
tion of plasma nicotine level in the second study. For 
the high-nicotine cigarette, 19 of 22 subjects experienced 
at least one sensation (mean around three), starting 
around 2.5 rain after lighting up. Together, these studies 
support the existence of a dose-response relationship for 
nicotine-induced euphoric sensations; suggest that they 
are more pronounced following overnight abstinence 
than following minimal deprivation, and in more depen- 
dent smokers; and characterize in detail the temporal 
features of these sensations. 
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Though early conceptualizations o f "  addiction" stressed 
the development of tolerance and the emergence of char- 
acteristic symptomatology upon withdrawal, most 
theorists now accept a broader definition of addiction 
that encompasses the pleasurable effects of a drug as 
well. The extent to which such sensations are associated 
with nicotine use, however, and to which they contribute 
to smoking behavior, are not well understood. The rela- 
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tive acceptability of nicotine in the past, compared with 
drugs like cocaine or amphetamines, is to some degree 
attributable to its failure to produce "highs" of suffi- 
cient magnitude to disrupt ongoing activity. In a study 
of around 1000 people seeking treatment for drug depen- 
dence, Kozlowski et al. (1989) found that cigarettes were 
rated as less pleasurable than alcohol or other drugs. 
In animals, the range of conditions under which nicotine 
demonstrates reinforcing stimulus properties is much 
more restricted than those for psychomotor stimulant, 
opiate, and sedative-hypnotic drugs (Dougherty et al. 
1981), 
On the other hand, nicotine has repeatedly been 
shown to produce EEG changes suggestive of cortical 
activation in both animals and humans, whether deliv- 
ered intravenously, via smoking, or via nicotine gum 
(see USDHHS 1988); the response is partially prevented 
by the nicotinic cholinergic antagonist mecamylamine 
(Pickworth et al. 1988), and tolerance develops rapidly 
(Hubbard and Gohd 1975). A series of studies carried 
out at the Addiction Research Center of the National 
Institute on Drug Abuse indicated that intravenous nico- 
tine injections produced dose-related decreases in alpha 
EEG activity, with multiple short episodes of euphoria 
appearing within 30 s of the injection (Jasinski et al. 
1984). Nicotine, whether administered via smoking or 
intravenously, has been shown to produce dose-related 
increases in scores on drug liking and euphoria, brief 
in duration, fairly rapid in onset (for smoking, occurring 
within a minute after completion of a cigarette), and 
showing the development of acute tolerance (Henn- 
ingfield 1984; Henningfield et al. 1987): intravenous in- 
fusion produces a "rush"  similar, though shorter in du- 
ration, to that produced by cocaine or morphine (Henn- 
ingfietd and Jasinski 1983; Henningfield etal. 1986). 
Liking scores are attenuated by mecamylamine in a 
dose-related manner (Henningfield 1983). 
This paper reports the results of two studies designed 
1) to replicate previous reports that smoking and nico- 
tine administration produce dose-related euphoria by 
asking subjects to depress a button when they experi- 
enced euphoric sensations, and to confirm this relation- 
ship using direct measures of plasma nicotine; 2) to tease 
out the effects of nondrug factors by comparing a usual- 
brand cigarette with a research cigarette; 3) to examine 
the effects of abstinence versus minimal deprivation 
upon these sensations; 4) to assess the possible role of 
degree of dependence; and 5) to characterize the tempo- 
ral features of such sensations. The apparatus used, a 
simplified version of a device used by Lukas and col- 
leagues to investigate the euphoriant effects of intrave- 
nous nicotine, alcohol, and other drugs (Lukas et al. 
1986), was intended to maximize our ability to capture 
evanescent effects by providing a continuous opportuni- 
ty for subject-initiated reporting rather than periodic in- 
vestigator-initiated querying. Experiment 1 was a pre- 
liminary study designed to verify the existence of the 
phenomenon under investigation and to determine 
which variables were likely to be of greatest interest. 
Subjects in this study smoked an ultralow-nicotine re- 
search cigarette (the control condition) in one session, 
a high-nicotine research cigarette in another session, and 
a usual-brand cigarette in a third (to assess the contribu- 
tion of "familiarity" or other non-nicotine factors to 
the phenomenon, as well as to establish that it was part 
of the experiential repertoire of smokers under habitual 
smoking conditions). Both the first cigarette of the day 
and a second cigarette, half an hour later, were assessed. 
Based on the results of this study, a follow-up study 
was conducted in which blood samples were collected 
in order to determine actual nicotine intake and to at- 
tempt to relate nicotine levels to euphoria more system- 
atically. Cigarettes of three distinct strengths (ultralow-, 
medium-, and high-nicotine) were used in an effort to 
establish a parametric dose-response relationship. Be- 
cause the first cigarette of the day produced the most 
pronounced effects in the initial study, only that ciga- 
rette was tested in the second study. 
Materials and methods 
Subjects 
Subjects for experiment 1 were ten male smokers recruited from 
the local community. Inclusion and exclusion criteria were as fol- 
lows: age 20-40 years; smoked at least 5 years; Fagerstrom Toler- 
ance Questionnaire (FTQ, a measure of nicotine dependence with 
possible scores ranging from 0 to 11; Fagerstrom 1978) at least 
5; usual brand of cigarettes nonmenthol and having a nicotine 
yield of >0.5 mg; no history of high blood pressure or cardiovas- 
cular problems; and not on any medications. Subjects for experi- 
ment 2 were 12 male smokers selected using the same inclusion 
and exclusion criteria except that minimum number of years 
smoked was 3 rather than 5 and nicotine yield of the subject's 
usual-brand cigarette was not restricted. 
Apparatus 
During experimental sessions, subjects were seated in an easy chair 
in a room equipped with a one-way mirror. Heart-rate was moni- 
tored and recorded using a Grass Polygraph (Model 7 B). All exper- 
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imental sequences were controlled by an IBM AT computer. Stan- 
dardized instructions were delivered via an Amiga computer 
equipped with a voice synthesizer; the Amiga was also used to 
present visual analogue scales, to which the subject responded using 
a mouse. No subject-experimenter intraction took place once a 
session began. During experiment 2, which involved blood sam- 
pling, an indwelling 18-gauge catheter was inserted in a left forearm 
vein and attached to a 1 m length of infusion-exfusion tubing that 
ran through a channel in the wall to allow unobtrusive withdrawal 
in the adjacent room; the line was heparinized, and samples were 
collected in tubes impregnated with EDTA to prevent clotting. 
They were kept on ice during the session, then centrifuged at 4 ° C, 
and kept frozen at - 8 0  ° C. Samples were assayed for nicotine 
and cotinine using HPLC (Hariharan et al. 1988). 
Standardized unfiltered high-nicotine (2.4 mg), medium-nico- 
tine (1.3 mg) and ultralow-nicotine research cigarettes (0.2 mg) 
used in these studies were manufactured by the Tobacco and Health 
Research Institute, University of Kentucky (2R1, 1A3, and 3A1, 
respectively). (The ultralow-nicotine cigarette was intended as a 
control condition and expected to produce minimal nicotine intake; 
the rationale was to help maintain subject blindness and to avoid 
the possible "psychoactive" effects of  non-nicotine substitutes.) 
Puff number and duration were measured using a gauge pressure 
transducer (LX 160-46; National Semiconductor); pressure 
changes produced by inhaling through a modified cigarette holder 
were transmitted to the pressure sensor via flexible plastic tubing, 
where they were converted to digital electric signals. Euphoric sen- 
sations were reported by the subject's pressing, for the duration 
of the sensation, a push-button with output to the AT, which com- 
puted time of onset and duration of each button press. 
Procedure 
Experiment 1. Subjects were screened by telephone. If they ap- 
peared to meet eligibility requirements and wished to participate 
in the study after hearing it described, they were scheduled for 
three 1-h sessions separated by at least a day. 
Subjects were requested to arrive at the lab at 8:00 a.m., with- 
out having smoked or ingested caffeine after midnight, and having 
eaten a standard breakfast (across the three sessions). Before the 
first session, the apparatus was demonstrated and a written in- 
formed consent document was obtained. Subjects were giving the 
following instructions for reporting euphoriant effects: "People 
sometimes report experiencing pleasurable sensations when they 
smoke that might be described as a rush, a buzz, or a high. Not 
everybody experiences these, and not all cigarettes produce these 
sensations. We are currently testing different blends of tobacco 
to determine how likely they are to produce these sensations. If 
you happen to experience any of these pleasurable sensations while 
smoking today, please depress the button and hold it down for 
the duration of the sensation." Electrodes were emplaced for col- 
lection of EKG data. 
At the start of the session, the subject was asked to smoke 
a cigarette, using the cigarette holder designed to record topogra- 
phy, and to depress the button to report a buzz as described above. 
For the next half hour, the subject was permitted to read a maga- 
zine. The subject then smoked a second cigarette identical to the 
first one, following the same procedure as for the first cigarette. 
Subjects were exposed to three sessions, separated by at least 
1 day. The first two, counterbalanced to control for order effects, 
involved a high-nicotine research cigarette on one day and an ultra- 
low-nicotine research cigarette on the other. During the third ses- 
sion - always the last, to avoid possible contamination of our 
assessment of strictly dose-related effects by interspersing a condi- 
tion in which nondrug factors might influence the dependent mea- 
sure - the subject smoked his usual-brand cigarettes. Sessions 1 
and 2 were run double-blind; session 3 was not. Subjects were 
paid $ 45 upon completion of the three sessions. 
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Experiment 2. Subjects who appeared to meet inclusion criteria 
and expressed a wish to participate in the study were invited to 
a 15-min familiarization, during which they were introduced to 
the experimental apparatus and asked to sign an informed consent 
document. They were then scheduled for three experimental ses- 
sions. 
Subjects were asked to report to the lab at 8:30 a.m., with 
instructions to abstain from smoking and caffeine intake after mid- 
night and to eat a standard breakfast. For all sessions, expired 
CO was tested, and any subject with a reading _>20 ppm was dis- 
missed. After insertion of an indwelling catheter and emplacement 
of electrodes for cardiac monitoring, subjects were permitted to 
read magazines during a 30-rain acclimation period. The subject 
was then asked to smoke, using the device for measuring topogra- 
phy and reporting sensations of euphoria by pressing the button 
as described above. 
Subjects were exposed to three sessions, scheduled 2-3 days 
apart. Sessions, presented in Latin square order to control for 
order effects, involved three cigarette conditions: ultralow-, medi- 
um-, and high-nicotine research cigarettes. Both subject and experi- 
menter were blind to experimental condition throughout. Subjects 
were paid $ 50 at the completion of the three sessions. 
Data analysis 
The principal data analyses wer carried out using repeated mea- 
sures factorial ANOVAs; Tukey's HSD test was used as appro- 
priate to specify differences among means. In addition, data from 
the two subject samples for the first cigarette of the day in the 
session when the high-nicotine cigarette was smoked, the only con- 
dition common to the two studies, were combined in an attempt 
I) to specify further the number and temporal characteristics of 
euphoric sensations and their relationship to smoking topography, 
and 2) to determine whether individual differences in smoking pat- 
terns might predict likelihood of experiencing euphoric sensations 
in response to smoking. In addition to the number and total dura- 
tion of button-presses, we calculated the average duration of a 
euphoric sensation, the mean number of puffs before the occur- 
rence of the first such sensation, the interval of time that elapsed 
from the onset of the first puff to the onset of the first euphoric 
sensation, and the interval of time between onset of the first eu- 
phoric sensation and the onset of the puff immediately preceding 
that sensation. Number and total duration of euphoric sensations 
were correlated with age, years smoked, FTQ score, cotinine level 
(for the 12 subjects in experiment 2 only), and total puff number. 
Results 
Subjects in experiment 1 had a mean age ( ± S D )  of  
27.7 _+ 6.5 years, had smoked a mean of 11.0_+ 5.7 years, 
smoked an average of  24.5_+6.0 cigarettes/day with a 
mean nicotine yield o f  0.94_+0.25 mg, and had mean 
FTQ scores of  6.2_+1.5. Subjects in experiment 2 had 
a mean age of  29.4_+6.4 years, had smoked a mean of  
11.9_+8.t years, and smoked an average of  22.2_+ 
5.8 cigarettes/day with a mean nicotine yield of  0.85 +_ 
0.31 rag. They had mean FTQ scores of  6.7_+ 1.4 and 
baseline cotinine levels o f  245.7_+ 148.8 ng/ml. FTQ 
scores and, in experiment 2, cotinine levels characterize 
both subject samples as moderately dependent smokers. 
The two samples did not differ significantly on any pa- 
rameters. All subjects in both  studies readily understood 
the definition of a euphoric sensation provided, and 
none expressed any reservations about  applying it to 















Fig. 1. Change in heart rate after smoking ultralow-nicotine re- 
search cigarettes, high-nicotine research cigarettes, and usual-brand 
cigarettes as the first (I~N) and second (Ell) cigarettes of the day 
(mean + SEM; N= 10) 
Experiment t 
Although nicotine intake was not measured in this study, 
pre- to post-smoking heart  rate boost  (see Fig. t)  showed 
highly significant differences for cigarette condition [ul- 
tralow-nicotine, high-nicotine, and usual-brand ciga- 
rettes; F(2,18) = 33.04, P < 0.0001], ordinal position [first 
versus second cigarette; / : ( t ,9)=12.56,  P<0 .01] ,  and 
condition x position iF(2,18) = 7.44, P < 0.005]. For the 
first cigarette of  the day, heart-rate boosts for both the 
high-nicotine and usual-brand cigarettes were signifi- 
cantly greater than that  for the low-nicotine cigarette 
(high versus low: P<0 .01  ; usual versus low: P<0 .01) ;  
the boost  for the usual-brand cigarette did not differ 
significantly f rom that for the high-nicotine cigarette. 
For the second cigarette of  the day, heart  rate boosts 
did not differ significantly among the three cigarettes. 
For the usual-brand cigarette, the boost  was significantly 
greater for the first cigarette of  the day ( P <  0.01). 
In the ultralow-nicotine condition, only four subjects 
(40%) reported experiencing euphoric sensations while 
smoking the first cigarette of  the day and two (20%) 
during the second. In the high-nicotine condition, eight 
subjects (80%) reported euphoric sensations during the 
first cigarette, and four (40%) during the second. Corre- 
sponding numbers for the usual-brand cigarette were 
six (60%) and three (30%). 
Figure 2 (upper panel) shows mean number  o f  reports 
of  euphoric sensations for each condition. Significant 
differences were observed for ordinal position [F(1,9)= 
10.80, P < 0.01], and for condition x position interaction 
iF(2,18) = 5.18, P < 0.05]. These effects are almost  entire- 
ly accounted for by the elevation in number  of  reports 
of  euphoric sensations for the first high-nicotine research 
cigarette of  the day, which was significantly greater than 
for the first ultralow-nicotine cigarette of  the day (P < 
0.05), as well as for the second high-nicotine cigarette 
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Fig. :2. Upper panel: number of reports of euphoric sensations (but- 
ton-presses) associated with smoking ultralow-nicotine research 
cigarettes, high-nicotine research cigarettes, and usual-brand ciga- 
rettes as the first (INfl) and second (Eli) cigarettes of the day (mean + 
SEM; N= 10). Lower panel: total duration of reports of euphoric 
sensations (time during which button was depressed) associated 
with smoking ultralow-nicotine research cigarettes, high-nicotine 
research cigarettes, and usual-brand cigarettes as the first (N~) and 
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Fig. 3. Upper panel: total number of reports of euphoric sensations 
(button-presses) associated with low-, medium-, and high-nicotine 
dosing conditions via research cigarette following overnight depri- 
vation (mean_+SEM, N= 12). Lower panel: total duration of re- 
ports of euphoric sensations (time during which button was de- 
pressed) associated with low-, medium-, and high-nicotine dosing 
conditions via research cigarette following overnight deprivation 
(mean± SEM, N= 12) 
( P <  0.05). Figure 2 (lower panel) shows total duration 
of reported euphoric sensations; no significant main or 
interaction effects were observed. 
Experiment 2 
Mean pre-smoking nicotine levels were 3.6_+0.9 ng/ml 
(maximum 9 ng/ml), 2.8_+1.1 ng/ml (maximum 11 ng/ 
ml) and 2.9_+0.8 ng/ml (maximum 7 ng/ml) for the ul- 
tralow-, medium-, and high-nicotine sessions, respective- 
ly, indicating good compliance with the instruction not 
to smoke after midnight on the previous night. 
Though mean +_ SEM plasma nicotine increment was 
low for the ultralow-nicotine condition (4.5 _+ 1.0 ng/mt), 
subjects foiled our attempt to administer parametric 
doses of nicotine by producing almost identical mean 
increments for the medium- and high-nicotine cigarettes 
(18.7+3.5 ng/ml and 17.5+2.5 ng/ml, respectively). A 
corresponding pattern was observed for both number 
and duration of button-presses, with means that were 
low for ultralow-nicotine cigarette (1.3_+l.0button 
presses; total duration 6.2 _+ 6.0 s) and higher but undif- 
ferentiated for the medium and high-nicotine cigarettes 
(2.8 _+ 1.0 and 2.6 + 0.8 button-presses, respectively; 
17.1 __ 10.4 and 18.7 __ 11.5 s total duration, respectively). 
Since all subjects received their lowest dose on the 
ultralow-nicotine day, we rearranged our medium and 
high conditions to reflect actual nicotine intake by 
switching the high and medium days for the six subjects 
who took in more nicotine from the medium- than from 
the high-nicotine cigarette. This manipulation produced 
a clean separation of  the medium- and high-nicotine 
conditions, with plasma nicotine increments of 13.4_+ 
1.5ng/ml and 22.8_+3.8 ng/ml, respectively. A highly 
significant linear trend was detected for these means 
[F(1,11) = 29.07, P < 0.00051. 
In the ultralow-nicotine dosing condition, only 4 of  
the 12 subjects (33%) experienced any euphoric sensa- 
tions. Corresponding figures for the medium-nicotine 
and high-nicotine dosing conditions were 10 subjects 
(83%) and 11 subjects (92%), respectively. 
Figure 3 (upper panel) shows mean number of reports 
of euphoric sensations for each nicotine dose. A signifi- 
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cant effect was observed for cigarette condition 
[F(2,22)=5.87, P<0.01]. Post hoc tests showed that 
number of reports of euphoric sensations presses for 
both the medium and high doses differed significantly 
from the ultra-low dose (low versus medium: P<0.05;  
low versus high: P < 0.05). Although number of euphor- 
ic sensations for the medium and high doses did not 
differ significantly from each other, a significant linear 
trend emerged [F(I , I I )= 8.50, P<0.05). For total dura- 
tion of reports of euphoric sensations (Fig. 3, lower pan- 
el), a linear dose-response effect failed to reach signifi- 
cance. 
Combined data for first cigarette~high-nicotine condition 
In the combined sample of 22 subjects, the number of 
button-presses made when a high-nicotine cigarette was 
smoked as the first cigarette of the day was significantly 
correlated with age ( r=+0.47 ,  P<0.05) and with 
number of years smoked (r-- + 0.48, P < 0.05). Total du- 
ration of button-presses was significantly correlated with 
total puff number (r= +0.43, P<0.05) and, in the 
12 subjects for whom cotinine levels were assayed, with 
cotinine (r = + 0.68, P < 0.05). No significant correlation 
was observed between either number or total duration 
of button-presses and FTQ scores. 
Nineteen of the 22 subjects experienced at least one 
euphoric sensation while smoking that cigarette. For 
those subjects, the mean (±SD)  number of button- 
presses was 2.8_+2.5, each button-press having a mean 
duration of t 1.1 _+ 25.5 s; for the entire cigarette, mean 
total time that the button was depressed was 35.1-t- 
77.7 s. Puff data are missing for one of these subjects; 
for the remaining 18, the time from the first puff to 
first button-press was 142.5_+95.6 s. The first button- 
press did not occur until subjects had taken a mean 
of 7.6_+3.6 puffs. The duration of the puff that most 
recently preceded the first button-press was 4.8_+9.6 s, 
and the time that elapsed between puff and button-press 
was 25.1 +36.6 s. 
D i s c u s s i o n  
Our findings for both studies support and extend dem- 
onstrations previously reported in the literature that nic- 
otine produces euphoric sensations in a dose-related 
manner. Although subjects failed to cooperate with our 
dosing manipulation (see Pomerleau et al. 1989) and 
managed, on average, to extract as much nicotine from 
their usual-brand cigarette and the medium-nicotine re- 
search cigarette as from the high-nicotine research ciga- 
rette (as evidenced by heart rate increases in experi- 
ment 1 and plasma nicotine boost in experiment 2), they 
were unable to obtain their presumably preferred nico- 
tine dose from the ultralow-nicotine research cigarette 
and reported correspondingly less euphoria. Further- 
more, when the data from experiment 2 are rearranged 
on the basis of nicotine plasma levels, an orderly dose- 
response curve emerges for number of euphoric sensa- 
tions. (It should be noted that puff-by-puff measures 
of plasma nicotine, or ideally, of brain and arterial levels, 
would help to substantiate this inference.) 
Because the evidence regarding differential nicotine 
exposure for the usual-brand and high-nicotine ciga- 
rettes is ambiguous in experiment 1, the additional im- 
pact of "familiarity" on the euphoriant effects of smok- 
ing cannot be determined. Clearly, however, euphoric 
sensations can be readily produced by unfamiliar re- 
search cigarettes, provided that they contain nicotine. 
It should be noted that despite our use in our instruc- 
tions of words like "high ", "buzz",  and "rush",  which 
are widely used slang terms explicitedly associated with 
drug-induced euphoria, we cannot be certain that the 
"pleasurable effects" reproted by the subjects indeed 
constituted "euphoria." In future studies, it would prob- 
ably be useful to include a post-study debriefing or some 
other subjective measures to provide a point of compari- 
son and to ensure that subjects clearly distinguished 
these pleasurable sensations from feelings of dizziness, 
intoxication, or relaxation. 
The results of experiment 1 are consistent with the 
possibility that tolerance to the euphoria-inducing prop- 
erties of nicotine develops to subsequent dosing (along 
with tolerance to its cardiovascular effects), since the 
response to the second cigarette was considerably atten- 
uated as compared to the response to the first cigarette. 
On the other hand, it is also possible that subjects con- 
fused "euphoria" with relief of withdrawal. In the ab- 
sence of measures of plasma nicotine, moreover, we can- 
not rule out the possibility that the observed differences 
in heart rate or reports of euphoric sensations are due 
simply to self-administration of lower doses of nicotine 
during the second cigarette of the day, rather than to 
differences in either tolerance or withdrawal symptoma- 
tology. 
Correlations between euphoria variables and smok- 
ing-related or demographic variables suggest that more 
experienced and more dependent smokers (as indicated 
by age, years smoked, and cotinine level, though not 
FTQ score) are more likely to experience euphoric sensa- 
tions during smoking - possibly because these smokers 
self-administer more nicotine (Pomerleau et al. 1983), or 
because they have "learned" to self-administer it in pat- 
terns conducive to the production of euphoric sensa- 
tions. A more systematic exploration of the relationship 
between nicotine dependence and the ability of nicotine 
to induce euphoria, in a larger number of subjects strati- 
fied for degree of dependence, would be necessary to 
substantiate this speculation. 
The mean number of reports of euphoric sensations 
per high-nicotine cigarette (for those subjects who re- 
ported any such sensations) was around three per ciga- 
rette, each lasting a mean of around 11 s. Thus, we can 
infer that these subjects experienced euphoric sensations 
for around 10% of the time involved in smoking a ciga- 
rette. Despite the fact that nicotine inhaled into the lungs 
reaches the brain in from 10 to 20 s (Benowitz 1988), 
the mean elapsed interval between onset of the first puff 
and onset of the first button-press was nearly 2.5 min 
- an interval comparable to, though slightly shorter 
than, that reported by Henningfield (1983, 1984). (The 
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shortest interval for any subject was 29 s, and the longest 
was 414 s, well after the cigarette was finished.) Since 
the mean duration of  the puff  immediately preceding 
the first button-press was less than 5 s, whereas the mean 
interval between onset of  that  puff  and onset o f  the 
first button-press was nearly 30 s, we conclude that  the 
onset of  a euphoric sensation typically does not  occur 
during a puff. In view of  the delay between puff  and 
sensation, it may  be that  the observed euphoriant  effects 
o f  nicotine result f rom the cascade of  neuroregulatory 
and neuromodula tory  effects initiated by the arrival in 
brain of  a series of  nicotine boli (see Pomerleau and 
Pomerleau 1984). 
Our study suggests that because euphoric sensations 
are experienced for only 10% of the time that  elapses 
during the smoking of  a cigarette, the phenomenon must  
be studied under conditions of  subject-initiated report-  
ing; queries made only at specified, standardized inter- 
vals (as is typically done) may  fail altogether to capture 
this effect - possibly explaining why this aspect o f  the 
smoking experience has been so largely neglected. Al- 
though controlled dosing methods undoubtedly help to 
regularize the temporal  characteristics of  this response, 
the extent to which variability can be reduced remains 
an empirical question; thus, both  se l f  administration 
and parametr ic  fixed dosing studies will be needed. Al- 
though experimental control of  dosing has obvious ad- 
vantages, it may  be that  smokers '  ability to adjust dose 
to maximize the favorable effects o f  nicotine (and mini- 
mize the toxic effects), and to achieve them reliably on 
demand,  are a critical component  in the reinforcement 
for smoking behavior - perhaps even more important  
than the actual magnitude of  the effects, Studies involv- 
ing concomitant  E E G  measurement  and studies using 
receptor antagonism (e.g., adrenergic or opiate blockers 
as well as mecamylamine)  may  also shed further light 
upon the ephemeral euphoriant  effects of  nicotine f rom 
smoking. 
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